← back to search

Melyssa Aronson

Unity Health Toronto · CA
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Genetic factors in colorectal cancer, BRCA gene mutations in cancer, Glioma Diagnosis and Treatment, and Cancer Genomics and Diagnostics.
h-index
44
citations
9,008
works
248
NIH funding
primary concept
Medicine
email

Recent publications

Patterns of hypermutation shape tumorigenesis and immunotherapy response in mismatch-repair-deficient glioma
Nature Genetics 2025cited by 1position: middledoi
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
The Lancet Oncology 2024cited by 58position: middledoi
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
Cancer Discovery 2023cited by 44position: middledoi
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency
Nature Medicine 2022cited by 141position: middledoi
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium
Hereditary Cancer in Clinical Practice 2022cited by 56position: middledoi
Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group
Journal of Medical Genetics 2021cited by 138position: firstdoi
Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study
The Lancet Oncology 2021cited by 117position: middledoi
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance
Journal of Clinical Oncology 2021cited by 98position: middledoi
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
Cancer Discovery 2020cited by 84position: middledoi
Cancers from Novel <i>Pole</i> -Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade
Cancer Research 2020cited by 25position: middledoi
Comprehensive Analysis of Hypermutation in Human Cancer
Cell 2017cited by 791position: middledoi
PMS2 monoallelic mutation carriers: the known unknown
Genetics in Medicine 2015cited by 67position: middledoi
Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer
European Urology 2012cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Cynthia Kuk · Sinai Health System1 papers (2012–2012)Peter J. Boström · University of Turku1 papers (2012–2012)Spring Holter · Ontario Institute for Cancer Research1 papers (2012–2012) · 1 papers (2012–2012)Bas van Rhijn · University of Regensburg1 papers (2012–2012) · 1 papers (2021–2021) · 1 papers (2021–2021)Kory Jasperson · Ambry Genetics (United States)1 papers (2021–2021)Neil Fleshner · University of Southern California1 papers (2012–2012)Kami Wolfe Schneider · University of Colorado Denver1 papers (2021–2021)Uri Tabori · Occupational Cancer Research Centre1 papers (2021–2021)Alexandre R. Zlotta · Collaborative Group (United States)1 papers (2012–2012)Heather Hampel · Ohio University1 papers (2021–2021)Michael A.S. Jewett · Princess Margaret Cancer Centre1 papers (2012–2012)Steven Gallinger · Ontario Institute for Cancer Research1 papers (2012–2012) · 1 papers (2012–2012)William D. Foulkes · McGill University Health Centre1 papers (2021–2021)Hagit Baris Feldman · University of Lausanne1 papers (2021–2021)Andrew Evans · Royal Derby Hospital1 papers (2012–2012)Chrystelle Colas · Université Paris Cité1 papers (2021–2021)